Secondary bacterial peritonitis: the biologic basis of treatment.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000276:immunology / Q000628:therapy; D002981:Clindamycin / Q000627:therapeutic use; D006801:Humans; D009504:Neutrophils / Q000276:immunology; D010537:Peritoneum / Q000382:microbiology; D010538:Peritonitis / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D010587:Phagocytosis; D011300:Preoperative Care; D013369:Subphrenic Abscess / Q000209:etiology / Q000628:therapy; D007507:Therapeutic Irrigation
D000900:Anti-Bacterial Agents; D002981:Clindamycin